Q32 Bio's market cap is currently $25.37M. The company's EPS TTM is $-0.78; its P/E ratio is ―; Q32 Bio is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-1.19. See an overview of income statement, balance sheet, and cash flow financials.
